Sufu Podcast

SUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder

Informações:

Synopsis

Moderator:  J. Quentin Clemens, MD, FACSRisk Profile of Anticholinergic Agents vs Beta-3 AgonistsPanelist: Anne M. Suskind, MD, MS, FACS, FPMRS Efficacy of Anticholinergic Agents vs Beta-3 AgonistsPanelist: Blayne Welk, MD What About Neurogenic Bladder?Panelist: Christopher S. Elliott, MD, PhD